The Southeast Lipid Association is pleased to announce Terry Jacobson, MD, as President.
Dr. Jacobson is currently the Director of the Office of Health Promotion and Disease Prevention at Emory University in Atlanta, GA. His specific expertise is in hyperlipidemia, nutrition and drug management of hypercholesterolemia, coronary heart disease (CHD) risk reduction strategies, and translating cardiovascular prevention into practice.ÂHe also serves as Co-Director of the Lipid and Cardiovascular Risk Reduction Program at Grady Health Systems in Atlanta, GA.
A graduate of Cornell University and Cornell University Medical College, Dr. Jacobson interned at New York University Medical Center/Bellevue Hospital in New York City. After completing a Robert Wood Johnson Clinical Scholar's Fellowship at the University of Pennsylvania, he became Director of Penn's Lipid Evaluation and CHD Risk Assessment Center. He is currently Professor of Medicine at Emory University and is an active clinician, educator, and researcher.
Dr. Jacobson has published and lectured extensively in the field of hypercholesterolemia, CHD risk modification, cost-effectiveness, lipid drug safety, and the dietary and pharmacologic treatment of hyperlipidemia. Since 1990, he has published over 100 peer reviewed articles in the Journal of the American Medical Association, the American Journal of Cardiology, Archives of Internal Medicine, Annals of Internal Medicine, the American Journal of Medicine, Current Opinion in Lipidology, and others. He has been invited to present at many national and international meetings on topics ranging from drug therapy for dyslipidemia to new directions in CHD prevention.
Dr. Jacobson has been elected to Fellowship of the American College of Physicians, the American College of Preventive Medicine, and the Council of Epidemiology and Prevention of the American Heart Association. He has served on the National Advisory Board of the United States Agency for Healthcare Research and Quality (AHRQ). He currently serves as a Board Member of the National Lipid Association and is President-Elect of the Southeast Lipid Association (SELA). He was the Chairman of the National Lipid Association's (NLA) Taskforce on Non-HDL Cholesterol and was involved in the Taskforce on Statin Safety and on the Taskforce for the Safety of Non-Statin Drugs. He is also a founding Board member of the Cardiovascular and Metabolic Health Foundation.
The National Lipid Association (NLA) is a multidisciplinary non-profit membership association that serves healthcare professionals who manage patients with lipid disorders and cardiovascular disease. The NLA's public health mission is to help reduce deaths related to high cholesterol.Â
Contacts:
National Lipid Association
Megan Seery, 904-309-6203
Publications
Manager
MSeery@lipid.org
